Health Care & Life Sciences » Pharmaceuticals | Ritter Pharmaceuticals Inc.

Ritter Pharmaceuticals Inc.

Ritter Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$3.68
Market Cap
$9.72 M
Shares Outstanding
9.04 M
Public Float
4.37 M

Profile

Address
1880 Century Park East
Los Angeles California 90067
United States
Employees -
Website http://www.ritterpharmaceuticals.com
Updated 07/08/2019
Ritter Pharmaceuticals, Inc. engages in the development of novel therapeutic products which modulate the human gut microbiome to treat gastrointestinal diseases. It focuses on the development and commercialization of RP-G28. The company was founded by Andrew J.

Financials

View All

Ira E. Ritter
Executive Chairman & Chief Strategic Officer
Andrew J. Ritter
President, CEO, Secretary & Director